Stereochemical Aspects of Drug Action and Disposition
暂无分享,去创建一个
[1] M. Eichelbaum,et al. Stereoselectivity in cardiovascular and biochemical action of calcium antagonists: Studies with the enantiomers of the dihydropyridine nitrendipine , 1995, Clinical pharmacology and therapeutics.
[2] R. Nation. Chirality in New Drug Development , 1994, Clinical pharmacokinetics.
[3] R. Day,et al. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. , 1994, British journal of clinical pharmacology.
[4] A. Burm,et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. , 1994, British journal of clinical pharmacology.
[5] C. Alm,et al. Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism , 1994, Clinical pharmacology and therapeutics.
[6] K. Higaki,et al. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney. , 1994, The Journal of pharmacology and experimental therapeutics.
[7] J. Schwartz,et al. Aging of women alters S‐verapamil pharmacokinetics and pharmacodynamics , 1994, Clinical pharmacology and therapeutics.
[8] M. Fromm,et al. An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy. , 1994, Circulation.
[9] B. Leyland-Jones,et al. Ifosfamide stereoselective dichloroethylation and neurotoxicity , 1994, The Lancet.
[10] F. Jamali,et al. Etodolac Clinical Pharmacokinetics , 1994, Clinical pharmacokinetics.
[11] J. Lötsch,et al. Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. , 1994, British journal of clinical pharmacology.
[12] H. Chrystyn,et al. Enantiomeric separation of R- and S-ifosfamide and their determination in serum from clinical subjects. , 1994, Journal of chromatography. B, Biomedical applications.
[13] M. Gnant,et al. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer. , 1994, British journal of clinical pharmacology.
[14] A. Somogyi,et al. Interaction of the stereoisomers of basic drugs with the uptake of tetraethylammonium by rat renal brush-border membrane vesicles. , 1994, Journal of Pharmacology and Experimental Therapeutics.
[15] S. Hall,et al. The role of coenzyme A in the biotransformation of 2-arylpropionic acids. , 1994, Chemico-biological interactions.
[16] S. Kitareewan,et al. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. , 1994, Biochemistry.
[17] C. Prakash,et al. Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects. , 1994, Pharmacogenetics.
[18] S. Fukushima,et al. Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats. , 1993, Journal of pharmaceutical sciences.
[19] Y. Masubuchi,et al. Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes. , 1993, Biochemical pharmacology.
[20] F. Jamali,et al. Stereoselective Dissolution of Propranolol Hydrochloride from Hydroxypropyl Methylcellulose Matrices , 1993, Pharmaceutical Research.
[21] R. Yates,et al. Metabolism and enantioselective pharmacokinetics of Casodex in man. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.
[22] R. Farinotti,et al. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[23] G. Granneman,et al. Stereoselective pharmacokinetics of pazinaclone, a new non-benzodiazepine anxiolytic, and its active metabolite in healthy subjects. , 1993, British journal of clinical pharmacology.
[24] P. Langguth,et al. The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers. , 1993, British journal of clinical pharmacology.
[25] J. Cody,et al. Interpretation of methamphetamine and amphetamine enantiomer data. , 1993, Journal of analytical toxicology.
[26] M. Eichelbaum,et al. Identification of P450 enzymes involved in metabolism of verapamil in humans , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] A. Ebihara,et al. The effects of age and gender on the stereoselective pharmacokinetics of verapamil , 1993, Clinical pharmacology and therapeutics.
[28] H. Thijssen,et al. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics , 1993, British journal of pharmacology.
[29] J. Turgeon,et al. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans. , 1993, The Journal of pharmacology and experimental therapeutics.
[30] D. Abernethy,et al. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration. , 1993, The Journal of pharmacology and experimental therapeutics.
[31] J. Turgeon,et al. Stereoselective disposition of (+/-)-sotalol at steady-state conditions. , 1993, British journal of clinical pharmacology.
[32] R. Day,et al. Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. , 1993, British journal of clinical pharmacology.
[33] J. Orgiazzi,et al. Purified D-thyroxine in athyreotic patients , 1993, The Lancet.
[34] G. Geisslinger,et al. Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. , 1993, British journal of clinical pharmacology.
[35] G. Geisslinger,et al. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. , 1993, British journal of anaesthesia.
[36] J. Karbwang,et al. The pharmacokinetics of quinine in patients with hepatitis. , 1993, British journal of clinical pharmacology.
[37] P. Augustijns,et al. Stereoselective Pharmacokinetic Properties of Chloroquine and De-Ethyl-Chloroquine in Humans , 1993, Clinical pharmacokinetics.
[38] N. White,et al. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. , 1993, British journal of clinical pharmacology.
[39] M. Wright,et al. Methods for the analysis of enantiomers of racemic drugs application to pharmacological and pharmacokinetic studies. , 1993, Journal of pharmacological and toxicological methods.
[40] C. Libersa,et al. Stereoselective Hydroxylation of Mexiletine in Human Liver Microsomes: Implication of P450IID6− A Preliminary Report , 1993, Journal of cardiovascular pharmacology.
[41] T. Andersson,et al. A study of the interaction of omeprazole and warfarin in anticoagulated patients. , 1992, British journal of clinical pharmacology.
[42] F. Jamali,et al. The Stereoselective Pharmacokinetics of Etodolac in Young and Elderly Subjects, and After Cholecystectomy , 1992, Journal of clinical pharmacology.
[43] G. Geisslinger,et al. Pure Enantiomers of 2‐Arylpropionic Acids: Tools in Pain Research and Improved Drugs in Rheumatology , 1992, Journal of clinical pharmacology.
[44] J. Caldwell. The importance of stereochemistry in drug action and disposition. , 1992, Journal of clinical pharmacology.
[45] D. Eyles,et al. Stereospecific reduction of haloperidol in human tissues. , 1992, Biochemical pharmacology.
[46] K. Higaki,et al. Stereoselective pharmacokinetics of a novel uricosuric antihypertensive diuretic in rats: pharmacokinetic interaction between enantiomers. , 1992, Journal of pharmaceutical sciences.
[47] P. Skolnick,et al. Isoflurane anesthesia is stereoselective. , 1992, European journal of pharmacology.
[48] M. Gibaldi,et al. Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects , 1992, Clinical pharmacology and therapeutics.
[49] J. Gerber,et al. Age and gender influence the stereoselective pharmacokinetics of propranolol. , 1992, The Journal of pharmacology and experimental therapeutics.
[50] G. Noseda,et al. The dispositional enantioselectivity of indobufen in man. , 1992, Biochemical pharmacology.
[51] P. McNamara,et al. Age and propranolol stereoselective disposition in humans , 1992, Clinical pharmacology and therapeutics.
[52] J. Le bras,et al. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. , 1992, British journal of clinical pharmacology.
[53] S. Hall,et al. Stereoselective disposition of flurbiprofen in normal volunteers. , 1992, British journal of clinical pharmacology.
[54] H. Hakusui,et al. Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.
[55] B. Obermayer-Pietsch,et al. Racemic (R,S)‐propranolol versus half‐dosed optically pure (S)‐propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels , 1992, Clinical pharmacology and therapeutics.
[56] M. Gibaldi,et al. The mechanism of the interaction between amiodarone and warfarin in humans , 1992, Clinical pharmacology and therapeutics.
[57] M. Eichelbaum,et al. Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects. , 1992, The Journal of pharmacology and experimental therapeutics.
[58] K. Midha,et al. Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[59] D. Smith,et al. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin. , 1991, British journal of clinical pharmacology.
[60] H. Hakusui,et al. Enantioselective disposition of ofloxacin in humans , 1991, Antimicrobial Agents and Chemotherapy.
[61] I. Niopas,et al. Further insight into the stereoselective interaction between warfarin and cimetidine in man. , 1991, British journal of clinical pharmacology.
[62] H. Ogata,et al. Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans. , 1991, Journal of pharmaceutical sciences.
[63] M. Eichelbaum,et al. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. , 1991, Molecular pharmacology.
[64] D. Roden,et al. Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers , 1991, Clinical pharmacology and therapeutics.
[65] R. Mehvar. Apparent stereoselectivity in propafenone uptake by human and rat erythrocytes , 1991, Biopharmaceutics & drug disposition.
[66] T. Vree,et al. Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates , 1991, Pharmaceutisch Weekblad.
[67] F. Jamali,et al. Pharmacokinetics of acebutolol enantiomers in humans. , 1991, Journal of pharmaceutical sciences.
[68] J. Clapham,et al. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. , 1991, Arzneimittel-Forschung.
[69] B. Peskar,et al. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition , 1991, Experientia.
[70] T. Miller,et al. Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. , 1991, Journal of the National Cancer Institute.
[71] W. Hooper,et al. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans , 1990, Clinical pharmacology and therapeutics.
[72] L. Aarons,et al. Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin. , 1990, British journal of clinical pharmacology.
[73] W. L. Nelson,et al. Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. , 1990, Biochemical pharmacology.
[74] G. Tucker,et al. Plasma concentrations of the stereoisomers of prilocaine after administration of the racemate: implications for toxicity? , 1990, British journal of anaesthesia.
[75] D. Breimer,et al. Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. , 1990, British journal of clinical pharmacology.
[76] M. Fujimaki,et al. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism. , 1990, Journal of pharmaceutical sciences.
[77] U. Klotz,et al. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. , 1990, The Journal of pharmacology and experimental therapeutics.
[78] K. Stoschitzky,et al. Different stereoselective effects of (R)‐ and (S)‐propafenone: Clinical pharmacologic, electrophysiologic, and radioligand binding studies , 1990, Clinical pharmacology and therapeutics.
[79] A. Wood,et al. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: Correlation between the clearance of (−)‐ and (+)‐propranolol , 1990, Clinical pharmacology and therapeutics.
[80] M. Bottorff,et al. Effects of age on the protein binding and disposition of propranolol stereoisomers , 1990, Clinical pharmacology and therapeutics.
[81] W. Lindner,et al. THE EFFECT OF D‐ VERSUS L‐ PROPRANOLOL IN THE TREATMENT OF HYPERTHYROIDISM , 1990, Clinical endocrinology.
[82] S. Kaye,et al. The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. , 1990, Biochemical pharmacology.
[83] H. Boudoulas,et al. Antiarrhythmic Activity and Unbound Concentrations of Disopyramide Enantiomers in Patients , 1990, Therapeutic drug monitoring.
[84] A. S. Gross,et al. Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype. , 1989, British journal of clinical pharmacology.
[85] P. Höglund,et al. No Effect of Terodiline on Anticoagulation Effect of Warfarin and Steady‐State Plasma Levels of Warfarin Enantiomers in Healthy Volunteers , 1989, Therapeutic drug monitoring.
[86] T. Walle,et al. A stereoselective central hypotensive action of atenolol. , 1989, The Journal of pharmacology and experimental therapeutics.
[87] A. Hertog,et al. The action of flecainide acetate and its enantiomers on mammalian non-myelinated nerve fibres , 1989, Pharmaceutisch Weekblad.
[88] L. Bertilsson,et al. Stereoselective disposition of racemic E‐10‐hydroxynortriptyline in human beings , 1989, Clinical pharmacology and therapeutics.
[89] M. S. Langley,et al. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. , 1989, Drugs.
[90] S. Hall,et al. Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status. , 1989, The Journal of pharmacology and experimental therapeutics.
[91] D. Roden,et al. Stereoselective disposition and pharmacologic activity of propafenone enantiomers. , 1989, Circulation.
[92] J. Lima,et al. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model. , 1989, Journal of cardiovascular pharmacology.
[93] G R Wilkinson,et al. Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. , 1989, The New England journal of medicine.
[94] P. Höglund,et al. Stereoselective Interaction of Omeprazole with Warfarin in Healthy Men , 1989, Therapeutic drug monitoring.
[95] W. Hooper,et al. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[96] M. Eichelbaum,et al. Stereoselective protein binding of verapamil enantiomers. , 1988, Biochemical pharmacology.
[97] L. Sansom,et al. Stereoselective drug disposition: potential for misinterpretation of drug disposition data. , 1988, British journal of clinical pharmacology.
[98] R. Le Verge,et al. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[99] M. Eichelbaum,et al. Electrophysiologic Effects of Dextro‐ and Levo‐Verapamil on Sinus Node and AV Node Function in Humans , 1988, Journal of cardiovascular pharmacology.
[100] H. Duff,et al. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. , 1988, Molecular pharmacology.
[101] M. Hollmann,et al. Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man. , 1988, Methods and findings in experimental and clinical pharmacology.
[102] E. Lunell,et al. No effect of roxithromycin on pharmacokinetic or pharmacodynamic properties of warfarin and its enantiomers. , 1988, Pharmacology & toxicology.
[103] P. Meffin,et al. Enantiospecific formation of fenoprofen coenzyme A thioester in vitro. , 1988, Biochemical Pharmacology.
[104] A. Russell,et al. Stereoselective pharmacokinetics of flurbiprofen in humans and rats. , 1988, Journal of pharmaceutical sciences.
[105] Y. W. Lam,et al. Stereoselectivity: An Issue of Significant Importance in Clinical Pharmacology , 1988, Pharmacotherapy.
[106] M. Rowland,et al. Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man. , 1988, British journal of clinical pharmacology.
[107] U. Quast,et al. Mechanism of Action and Systemic and Regional Hemodynamics of the Potassium Channel Activator BRL34915 and Its Enantiomers , 1988, Circulation research.
[108] R. Blouin,et al. Age‐associated stereoselective alterations in hexobarbital metabolism , 1988, Clinical pharmacology and therapeutics.
[109] J. Nathanson. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process. , 1988, The Journal of pharmacology and experimental therapeutics.
[110] L. Bertilsson,et al. Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine. , 1988, British journal of clinical pharmacology.
[111] S. Toon,et al. The racemic metoprolol H2‐antagonist interaction , 1988, Clinical pharmacology and therapeutics.
[112] C. Peterson,et al. D‐verapamil and L‐verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro , 1988, International journal of cancer.
[113] E. Smith,et al. Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. , 1988, Journal of cardiovascular pharmacology.
[114] A. Uprichard,et al. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation. , 1988, Journal of cardiovascular pharmacology.
[115] M. S. Ching,et al. Differences in the binding of quinine and quinidine to plasma proteins. , 1987, British journal of clinical pharmacology.
[116] G. Fromm,et al. Comparison of L‐baclofen and racernic baclofen in trigeminal neuralgia , 1987, Neurology.
[117] M. Gibaldi,et al. The mechanism of the warfarin‐rifampin drug interaction in humans , 1987, Clinical pharmacology and therapeutics.
[118] A. Tattersfield,et al. Comparison of the airway response to eye drops of timolol and its isomer L-714,465 in asthmatic subjects. , 1987, British journal of clinical pharmacology.
[119] W. Trager,et al. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans , 1987, Clinical pharmacology and therapeutics.
[120] L. Aarons,et al. Enoxacin‐warfarin interaction: Pharmacokinetic and stereochemical aspects , 1987, Clinical pharmacology and therapeutics.
[121] D. Drayer,et al. Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. , 1987, The Journal of pharmacology and experimental therapeutics.
[122] G. Breese,et al. Pharmacology of the enantiomers of threo-methylphenidate. , 1987, The Journal of pharmacology and experimental therapeutics.
[123] Ö. Ericsson,et al. Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.
[124] A. Breckenridge,et al. Enantiomers of warfarin and vitamin K1 metabolism. , 1986, British journal of clinical pharmacology.
[125] M. Alkondon,et al. Nonstereoselective aspects of propranolol pharmacodynamics. , 1986, Canadian journal of physiology and pharmacology.
[126] J. Kuritsky,et al. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. , 1986, American journal of ophthalmology.
[127] D. Notterman,et al. Stereoselective renal tubular secretion of quinidine and quinine , 1986, Clinical pharmacology and therapeutics.
[128] P. Schechter,et al. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S‐enantiomer , 1986, Clinical pharmacology and therapeutics.
[129] K. Williams,et al. The stereoselective uptake of ibuprofen enantiomers into adipose tissue. , 1986, Biochemical pharmacology.
[130] F. Sjöqvist,et al. Protein binding of chloroquine enantiomers and desethylchloroquine. , 1986, British journal of clinical pharmacology.
[131] M. Curtis,et al. The mechanism of action of the optical enantiomers of verapamil against ischaemia‐induced arrhythmias in the conscious rat , 1986, British journal of pharmacology.
[132] W. L. Nelson,et al. In vivo interaction of the enantiomers of disopyramide in human subjects , 1986, Journal of Pharmacokinetics and Biopharmaceutics.
[133] D. Greenblatt,et al. Pharmacokinetics and dynamics of penbutolol in humans: Evidence for pathway-specific stereoselective clearance , 1986, Klinische Wochenschrift.
[134] Z. Tang,et al. Pharmacokinetics of (±)‐, (+)‐, and (−)‐gossypol in humans and dogs , 1986, Clinical pharmacology and therapeutics.
[135] A. Breckenridge,et al. Stereoselective interaction between the R enantiomer of warfarin and cimetidine. , 1986, British journal of clinical pharmacology.
[136] J. R. Schmid,et al. Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers. , 1986, Journal of medicinal chemistry.
[137] B. Diquet,et al. The warfarin-cimetidine interaction: stereochemical considerations. , 1986, British journal of clinical pharmacology.
[138] C. Leier,et al. Cardiovascular effects of ophthalmic timolol. , 1986, Annals of internal medicine.
[139] M. Gibaldi,et al. The warfarin‐sulfinpyrazone interaction: stereochemical considerations , 1986, Clinical pharmacology and therapeutics.
[140] R. Ruffolo,et al. Effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine on cardiac function in pithed rats. , 1985, The Journal of pharmacology and experimental therapeutics.
[141] S. Bjorkman. Stereoselective disposition of indoprofen in surgical patients. , 1985 .
[142] K. Giacomini,et al. Stereoselective renal clearance of pindolol in humans. , 1985, The Journal of clinical investigation.
[143] R. Branch,et al. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation , 1985, Clinical pharmacology and therapeutics.
[144] H. Boudoulas,et al. Stereoselective pharmacokinetics of disopyramide enantiomers in man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[145] R. Branch,et al. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. , 1985, The Journal of pharmacology and experimental therapeutics.
[146] M. Bechem,et al. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. , 1985, European journal of pharmacology.
[147] U. Ruegg,et al. Stereoselectivity at the Calcium Channel: Opposite Action of the Enantiomers of a 1,4‐Dihydropyridine , 1985, Journal of cardiovascular pharmacology.
[148] M. Eichelbaum,et al. Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.
[149] H. Glossmann,et al. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart , 1985, British journal of pharmacology.
[150] K. Netter. Progress in drug metabolism , 1985 .
[151] M. Eichelbaum,et al. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. , 1985, American heart journal.
[152] J Schüttler,et al. Comparative pharmacology of the ketamine isomers. Studies in volunteers. , 1985, British journal of anaesthesia.
[153] C. Gorman,et al. L‐Thyroxine contamination of pharmaceutical D‐thyroxine: Probable cause of therapeutic effect , 1984, Clinical pharmacology and therapeutics.
[154] M. Eichelbaum,et al. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.
[155] T. Walle,et al. Stereoselective ring oxidation of propranolol in man. , 1984, British journal of clinical pharmacology.
[156] M. Contin,et al. Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. , 1984, British journal of clinical pharmacology.
[157] M. Simonyi. On chiral drug action , 1984, Medicinal research reviews.
[158] R. Branch,et al. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans. , 1984, The Journal of pharmacology and experimental therapeutics.
[159] R. Stone,et al. The effect of d-timolol on intraocular pressure in patients with ocular hypertension. , 1984, American journal of ophthalmology.
[160] G. Wilkinson,et al. Polymorphic ability to metabolize propranolol alters 4‐hydroxypropranolol levels but not beta blockade , 1984, Clinical pharmacology and therapeutics.
[161] G. Tucker,et al. The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol. , 1984, British journal of clinical pharmacology.
[162] T. Walle,et al. Stereoselective clearance and distribution of intravenous propranolol , 1984, Clinical pharmacology and therapeutics.
[163] G. Tucker,et al. Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers , 1983, Clinical pharmacology and therapeutics.
[164] E. Chan,et al. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. , 1983, British journal of clinical pharmacology.
[165] J. Caldwell,et al. The metabolic chiral inversion of 2‐arylpropionic acids—a novel route with pharmacological consequences , 1983, The Journal of pharmacy and pharmacology.
[166] P. Timmermans. Stereochemistry and Biological Activity of Drugs , 1983 .
[167] R. Pinder,et al. The potential therapeutic role of the enantiomers and metabolites of mianserin. , 1983, British journal of clinical pharmacology.
[168] G. P. Levy,et al. THE α‐ AND β‐ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANAESTHETIZED DOGS AND IN ISOLATED TISSUES , 1982 .
[169] R. O'Reilly. Ticrynafen‐racemic warfarin interaction: Hepatotoxic or stereoselective? , 1982, Clinical pharmacology and therapeutics.
[170] J. Hermansson,et al. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man. , 1982, British journal of clinical pharmacology.
[171] N. Holford,et al. Stereoselective disposition and glucuronidation of propranolol in humans. , 1982, Journal of pharmaceutical sciences.
[172] R. O'Reilly. Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man , 1982, Circulation.
[173] S. Nelson,et al. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol. , 1981, The Journal of pharmacology and experimental therapeutics.
[174] R. Branch,et al. Stereoselective metabolism of mephenytoin in man. , 1981, The Journal of pharmacology and experimental therapeutics.
[175] T. Tsuruo,et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.
[176] E. Sellers,et al. Methadone binding to orosomucoid (α1‐acid glycoprotein): Determinant of free fraction in plasma , 1981 .
[177] S. Riegelman,et al. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma. , 1980, The Journal of pharmacology and experimental therapeutics.
[178] K. Giacomini,et al. Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum. , 1980, Life sciences.
[179] M. Eichelbaum,et al. Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment , 1980, Klinische Wochenschrift.
[180] W. Trager,et al. Interaction of secobarbital with warfarin pseudoracemates , 1980, Clinical pharmacology and therapeutics.
[181] R. Larkins,et al. D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. , 1980, British medical journal.
[182] T. Yanagisawa,et al. Coronary Vasodilator and Cardiac Effects of Optical Isomers of Verapamil in the Dog , 1980, Journal of cardiovascular pharmacology.
[183] P. White,et al. Pharmacology of Ketamine Isomers in Surgical Patients , 1980, Anesthesiology.
[184] W. Trager,et al. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man. , 1980, The Journal of clinical investigation.
[185] G. Cheymol,et al. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs. , 1980, The Journal of pharmacology and experimental therapeutics.
[186] R. O'Reilly. Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. , 1980, The New England journal of medicine.
[187] E. R. Shepard,et al. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans. , 1979, Drug metabolism and disposition: the biological fate of chemicals.
[188] M. Eichelbaum,et al. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect , 1979, European Journal of Clinical Pharmacology.
[189] H. Haas,et al. The biological activity of d-baclofen (Lipresal®) , 1978 .
[190] F. Reynolds,et al. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. , 1978, British journal of clinical pharmacology.
[191] J. Idle,et al. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.
[192] N. Gerber,et al. Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers , 1977, Clinical pharmacology and therapeutics.
[193] P. Murphy,et al. Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.
[194] T. Meinertz,et al. The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies , 1976, Clinical pharmacology and therapeutics.
[195] R. O'Reilly. The stereoselective interaction of warfarin and metronidazole in man. , 1976, The New England journal of medicine.
[196] W. Wechter,et al. Isomeric inversion of ibuprofen (R)-enantiomer in humans. , 1976, Journal of pharmaceutical sciences.
[197] D. Miller,et al. Molecular geometry and adrenergic drug activity. , 1974, Pharmacological reviews.
[198] A. Breckenridge,et al. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. , 1974, The Journal of clinical investigation.
[199] J. Morris,et al. Active Transport of L-Dopa in the Intestine , 1973, Nature.
[200] J. Stamler. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.
[201] D. Shand,et al. Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.
[202] George C. Cotzias,et al. Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.
[203] A. Barrett,et al. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.
[204] L. Schiffer,et al. Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.
[205] A. M. Lands,et al. $$Word$$ PHARMACOLOGIC ACTIVITY OF THE OPTICAL ISOMERS OF ISOPROPYLARTERENOL (ISUPREL) COMPARED WITH THAT OF THE OPTICALLY INACTIVE ANALOG 1-(3,4-DIHYDROXY PHENYL)-2-ISOPROPYLAMINOETHANE HCl , 1954 .
[206] K. Strein,et al. Pharmacological characteristics of the stereoisomers of carvedilol , 2005, European Journal of Clinical Pharmacology.
[207] C. A. Stone,et al. R-Enantiomer of timolol: a potential selective ocular antihypertensive agent , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[208] M. Nishikata,et al. Enantioselective pharmacokinetics of homochlorcyclizine II: disposition and metabolism of (+)-, (−)- and racemic homochlorcyclizine after oral administration to man , 2005, European Journal of Clinical Pharmacology.
[209] S. Toon,et al. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man , 2004, European Journal of Clinical Pharmacology.
[210] L. Sansom,et al. Stereoselective plasma protein binding of ibuprofen enantiomers , 2004, European Journal of Clinical Pharmacology.
[211] H. Brodthagen,et al. Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker , 2004, European Journal of Clinical Pharmacology.
[212] E. J. Ariëns. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology , 2004, European Journal of Clinical Pharmacology.
[213] H. Schoemaker,et al. Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics , 2004, European Journal of Clinical Pharmacology.
[214] A. Evans. Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs , 2004, European Journal of Clinical Pharmacology.
[215] W. Krause,et al. Pharmacokinetics of (+)-rolipram and (−)-rolipram in healthy volunteers , 2004, European Journal of Clinical Pharmacology.
[216] M. Eichelbaum,et al. Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines , 2004, European Journal of Clinical Pharmacology.
[217] T. Kronbach,et al. Stereo- and regioselectivity of hepatic oxidation in man — Effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation , 2004, European Journal of Clinical Pharmacology.
[218] E. Mutschler,et al. Single- and multiple-dose pharmacokinetics of R-(−)- and S-(+)-prenylamine in man , 2004, European Journal of Clinical Pharmacology.
[219] H. Thijssen,et al. Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol , 2004, European Journal of Clinical Pharmacology.
[220] R. Nation,et al. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate. , 1994, British journal of clinical pharmacology.
[221] T. Walle,et al. The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. , 1994, British journal of clinical pharmacology.
[222] B. J. Cooke. Chirality of methamphetamine and amphetamine from workplace urine samples. , 1994, Journal of Analytical Toxicology.
[223] N. Cutler,et al. Pharmacodynamics and drug development : perspectives in clinical pharmacology , 1994 .
[224] M. Eichelbaum,et al. Enantioselective gallopamil protein binding. , 1993, Chirality.
[225] E. Chan,et al. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone. , 1993, Chirality.
[226] J. Millership,et al. Commonly used chiral drugs: a survey. , 1993, Chirality.
[227] J. Longstreth,et al. Stereospecific determination of the in vitro dissolution of modified release formulations of (±)-verapamil , 1993 .
[228] J. Young,et al. Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer. , 1993, Chirality.
[229] K. Stoschitzky,et al. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. , 1993, Chirality.
[230] H. Zhou,et al. Lack of effect of ageing on the stereochemical disposition of propranolol. , 1992, British journal of clinical pharmacology.
[231] M. Eichelbaum,et al. Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers. , 1992, British journal of clinical pharmacology.
[232] R. Le Verge,et al. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. , 1992, Chirality.
[233] T. Aoyama,et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. , 1992, Chemical research in toxicology.
[234] M. Gibaldi,et al. Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin. , 1991, Chirality.
[235] J. Caldwell,et al. Regulatory aspects of the development of chiral drugs in Japan : a status report , 1991 .
[236] M. Cayen. Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development , 1991 .
[237] T. Grogan,et al. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[238] K M Williams,et al. Enantiomers in arthritic disorders. , 1990, Pharmacology & therapeutics.
[239] G. Tucker,et al. Enantiomer specific pharmacokinetics. , 1990, Pharmacology & therapeutics.
[240] W. Hooper,et al. Enantioselective binding of mephobarbital to plasma proteins. , 1990, Chirality.
[241] B Testa,et al. Racemates versus enantiomers in drug development: dogmatism or pragmatism? , 1990, Chirality.
[242] O. Okazaki,et al. Stereoselective metabolic disposition of enantiomers of ofloxacin in rats. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[243] B. Testa. Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions. , 1989, Chirality.
[244] C. Kerr,et al. The pharmacokinetics of the enantiomers of mexiletine in humans. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[245] G. Baker,et al. Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. , 1989, Chirality.
[246] K. Stoschitzky,et al. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol. , 1989, Chirality.
[247] J. Paulson,et al. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. , 1989, British journal of clinical pharmacology.
[248] B. K. Park,et al. Warfarin: metabolism and mode of action. , 1988, Biochemical pharmacology.
[249] M. Eichelbaum,et al. Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man. , 1988, Biochemical pharmacology.
[250] T. Walle,et al. Stereoselective delivery and actions of beta receptor antagonists. , 1988, Biochemical pharmacology.
[251] J. Caldwell,et al. Metabolism of xenobiotics , 1988 .
[252] E. J. Ariëns,et al. Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. , 1988, Biochemical pharmacology.
[253] B. Testa. Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivation. , 1988, Biochemical pharmacology.
[254] J. Caldwell,et al. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. , 1988, Biochemical pharmacology.
[255] J. Bada,et al. Dietary D-amino acids. , 1987, Annual review of nutrition.
[256] R. Wolen,et al. Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. , 1985, Journal of pharmaceutical sciences.
[257] J. Sawynok,et al. D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord. , 1985, Pharmacology.
[258] B. Testa,et al. The influence of stereochemical factors on drug disposition. , 1973, Drug metabolism reviews.
[259] L. H. Easson,et al. Studies on the relationship between chemical constitution and physiological action: Molecular dissymmetry and physiological activity. , 1933, The Biochemical journal.